Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro

Cancer Immunology, Immunotherapy

Volumn 58, Issue 11, 2009, Pages 1833-1843

  Gervais, Alban ^a   Eymard, Jean Christophe ^a   Toulmonde, Eric ^b   Bernard, Jacky ^a  

^a INSTITUT JEAN GODINOT   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Adjuvant; Alloreactivity; Antigen specific T cell; Dendritic cell; Tumour associated antigen

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; MATRIX PROTEIN; MELAN A; TUMOR ANTIGEN; CYTOKINE;

ALLELE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL SCREENING; CELL SELECTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; T LYMPHOCYTE;

ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HLA-A2 ANTIGEN; HUMANS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 70349776504     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0694-7     Document Type: Article

References (59)

1. WJ Lesterhuis EH Aarntzen IJ De Vries DH Schuurhuis CG Figdor GJ Adema et al. 2008 Dendritic cell vaccines in melanoma: from promise to proof? Crit Rev Oncol Hematol 66 2 118 134
2. JW Fabre 2001 The allogeneic response and tumor immunity Nat Med 7 6 649 652
3. NW Nisbet M Simonsen M Zaleski 1969 The frequency of antigen-sensitive cells in tissue transplantation. A commentary on clonal selection J Exp Med 129 3 459 467
4. EJ Suchin PB Langmuir E Palmer MH Sayegh AD Wells LA Turka 2001 Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question J Immunol 166 2 973 981
5. SG Danzer H Kirchner L Rink 1994 Cytokine interactions in human mixed lymphocyte culture Transplantation 57 11 1638 1642
6. SR Burrows R Khanna JM Burrows DJ Moss 1994 An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease J Exp Med 179 4 1155 1161
7. MA Brehm TG Markees KA Daniels DL Greiner AA Rossini RM Welsh 2003 Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections J Immunol 170 8 4077 4086
8. JH Chewning CN Gudme KC Hsu A Selvakumar B Dupont 2007 KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro J Immunol 179 2 854 868
9. T Igarashi J Wynberg R Srinivasan B Becknell JP McCoy Jr Y Takahashi et al. 2004 Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells Blood 104 1 170 177
10. S Patterson I Kotsianidis A Almeida M Politou A Rahemtulla B Matthew et al. 2005 Human invariant NKT cells are required for effective in vitro alloresponses J Immunol 175 8 5087 5094
11. PL Thompson S Dessureault 2007 Tumor cell vaccines Adv Exp Med Biol 601 345 355
12. JE Ward DG McNeel 2007 GVAX: an allogeneic, whole-cell, GM-CSF-secreting cellular immunotherapy for the treatment of prostate cancer Expert Opin Biol Ther 7 12 1893 1902
13. MV Peshwa C Benike M Dupuis SK Kundu EG Engleman TC Merigan et al. 1998 Generation of primary peptide-specific CD8 + cytotoxic T-lymphocytes in vitro using allogeneic dendritic cells Cell Transplant 7 1 1 9
14. M Peiper PS Goedegebuure TJ Eberlein 1997 Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells Surgery 122 2 235 241
15. SJ Santegoets MW Schreurs AJ Masterson YP Liu S Goletz H Baumeister et al. 2006 In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line Cancer Immunol Immunother 55 12 1480 1490
16. V Russo D Zhou C Sartirana P Rovere A Villa S Rossini et al. 2000 Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells Blood 95 11 3473 3477
17. A Marten S Renoth T Heinicke P Albers A Pauli U Mey et al. 2003 Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma Hum Gene Ther 14 5 483 494
18. AR Neves LF Ensina LB Anselmo KR Leite AC Buzaid LH Camara-Lopes et al. 2005 Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions Cancer Immunol Immunother 54 1 61 66
19. F Xu YJ Ye ZR Cui S Wang 2005 Allogeneic dendritomas induce anti-tumour immunity against metastatic colon cancer Scand J Immunol 61 4 364 369
20. U Trefzer G Herberth K Wohlan A Milling M Thiemann T Sherev et al. 2004 Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients Int J Cancer 110 5 730 740
21. Z Yu Q Fan X Hao H Long 2004 Specific antitumor effects of tumor vaccine produced by electrofusion between osteosarcoma cell and dendritic cell in rats Cell Mol Immunol 1 6 454 460
22. DE Avigan B Vasir DJ George WK Oh MB Atkins DF McDermott et al. 2007 Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma J Immunother 30 7 749 761
23. Y Tanaka S Koido D Chen SJ Gendler D Kufe J Gong 2001 Vaccination with allogeneic dendritic cells fused to carcinoma cells induces antitumor immunity in MUC1 transgenic mice Clin Immunol 101 2 192 200
24. JA Barbuto LF Ensina AR Neves P Bergami-Santos KR Leite R Marques et al. 2004 Dendritic cell-tumor cell hybrid vaccination for metastatic cancer Cancer Immunol Immunother 53 12 1111 1118
25. TD Gruijl AJ van den Eertwegh HM Pinedo RJ Scheper 2008 Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines Cancer Immunol Immunother 57 10 1569 1577
26. DI Gabrilovich J Corak IF Ciernik D Kavanaugh DP Carbone 1997 Decreased antigen presentation by dendritic cells in patients with breast cancer Clin Cancer Res 3 3 483 490
27. M Andrieu D Chassin JF Desoutter I Bouchaert M Baillet D Hanau et al. 2001 Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8 + T lymphocytes AIDS Res Hum Retroviruses 17 14 1365 1370
28. JW Wells CJ Cowled D Darling BA Guinn F Farzaneh A Noble et al. 2007 Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity Cancer Immunol Immunother 56 12 1861 1873
29. A Merrick RM Diaz D O'Donnell P Selby R Vile A Melcher 2008 Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naive cytotoxic priming and anti-tumour therapy Cancer Immunol Immunother 57 6 897 906
30. J Simova J Bubenik J Bieblova M Indrova T Jandlova 2005 Immunotherapeutic efficacy of vaccines generated by fusion of dendritic cells and HPV16-associated tumour cells Folia Biol (Praha) 51 1 19 24
31. T Suzuki T Fukuhara M Tanaka A Nakamura K Akiyama T Sakakibara et al. 2005 Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells Clin Cancer Res 11 1 58 66
32. T Yasuda T Kamigaki K Kawasaki T Nakamura M Yamamoto K Kanemitsu et al. 2007 Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma Cancer Immunol Immunother 56 7 1025 1036
33. J Gong N Nikrui D Chen S Koido Z Wu Y Tanaka et al. 2000 Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity J Immunol 165 3 1705 1711
34. J Bernard D Ittelet A Christoph G Potron JC Adjizian S Kochman et al. 1998 Adherent-free generation of functional dendritic cells from purified blood monocytes in view of potential clinical use Hematol Cell Ther 40 1 17 26
35. RA Henderson H Michel K Sakaguchi 1992 HLA-A21-associated peptides from a mutant cell line: a second pathway of antigen presentation Science 255 1264 1266
36. H Lecoeur M Fevrier S Garcia Y Riviere ML Gougeon 2001 A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity J Immunol Methods 253 1-2 177 187
37. B Sander J Andersson U Andersson 1991 Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure Immunol Rev 119 65 93
38. S Prasad I Humphreys S Kireta RB Gilchrist P Bardy GR Russ et al. 2006 MHC Class II DRB genotyping is highly predictive of in vitro alloreactivity in the common marmoset J Immunol Methods 314 1-2 153 163
39. V Cukrova M Loudova I Sramkova L Dolezalova A Vitek 1998 Predictive value of HLA class II PCR typing for the outcome of mixed lymphocyte reaction Folia Biol (Praha) 44 4 137 141
40. O Olerup E Moller U Persson 1990 HLA-DP incompatibilities induce significant proliferation in primary mixed lymphocyte cultures in HLA-A, -B, -DR and -DQ compatible individuals: implications for allogeneic bone marrow transplantation Tissue Antigens 36 5 194 202
41. T Suehiro M Shimada K Kishikawa T Shimura Y Soejima T Yoshizumi et al. 2005 Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation Liver Int 25 6 1182 1188
42. A Cesbron P Moreau N Milpied JY Muller JL Harousseau JD Bignon 1990 Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation Bone Marrow Transplant 6 5 337 340
43. RA Smith R Belcher 1987 Disparity in HLA-DR typing and mixed lymphocyte culture reactivity Ann Clin Lab Sci 17 5 318 323
44. WJ Jordan MA Ritter 2002 Optimal analysis of composite cytokine responses during alloreactivity J Immunol Methods 260 1-2 1 14
45. JL Ferrara S Abhyankar DG Gilliland 1993 Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1 Transplant Proc 25 1 Pt 2 1216 1217
46. RJ Rentenaar JL Vosters FN van Diepen EB Remmerswaal RA van Lier IJ ten Berge 2002 Differentiation of human alloreactive CD8(+) T cells in vitro Immunology 105 3 278 285
47. XN Wang C Lange U Schulz L Sviland G Eissner KM Oliver et al. 2002 Interleukin-10 modulation of alloreactivity and graft-versus-host reactions Transplantation 74 6 772 778
48. S Yamazaki M Patel A Harper A Bonito H Fukuyama M Pack et al. 2006 Effective expansion of alloantigen-specific Foxp3 + CD25 + CD4 + regulatory T cells by dendritic cells during the mixed leukocyte reaction Proc Natl Acad Sci USA 103 8 2758 2763
49. A Demirkiran A Kok J Kwekkeboom JG Kusters HJ Metselaar HW Tilanus et al. 2006 Low circulating regulatory T-cell levels after acute rejection in liver transplantation Liver Transpl 12 2 277 284
50. G Yu X Xu MD Vu ED Kilpatrick XC Li 2006 NK cells promote transplant tolerance by killing donor antigen-presenting cells J Exp Med 203 8 1851 1858
51. WC Lee C Zhong S Qian Y Wan J Gauldie Z Mi et al. 1998 Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta Transplantation 66 12 1810 1817
52. EM Mickelson G Longton C Anasetti E Petersdorf P Martin LA Guthrie et al. 1996 Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation Tissue Antigens 47 1 27 36
53. F Bendjelloul TS Desin AS Shoker 2004 Donor non-specific IFN-gamma production by primed alloreactive cells as a potential screening test to predict the alloimmune response Transpl Immunol 12 2 167 176
54. SD De A Bishara CS Witt A Nagler C Brautbar S Slavin et al. 2005 Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants Tissue Antigens 65 6 519 528
55. Y Morishima T Yabe K Matsuo K Kashiwase H Inoko H Saji et al. 2007 Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor Biol Blood Marrow Transplant 13 3 315 328
56. SS Farag A Bacigalupo M Eapen C Hurley B Dupont MA Caligiuri et al. 2006 The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry Biol Blood Marrow Transplant 12 8 876 884
57. B Almand JI Clark E Nikitina J van Beynen NR English SC Knight et al. 2001 Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer J Immunol 166 1 678 689
58. D Laurin J Kanitakis J Bienvenu C Bardin J Bernaud S Lebecque et al. 2004 Allogeneic reaction induces dendritic cell maturation through proinflammatory cytokine secretion Transplantation 77 2 267 275
59. I Hus J Rolinski J Tabarkiewicz K Wojas A Bojarska-Junak J Greiner et al. 2005 Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukaemia Leukemia 19 9 1621 1627